Summary of transactions
On January 23, 2026, Jeffrey P. Klenk, Executive Vice President at Travelers Companies (NYSE: TRV), sold 16,712 shares of common stock for approximately $4.6 million. The reported sales price was $279.7746 per share, representing a weighted average drawn from prices between $279.60 and $280.25. The filing notes that the Reporting Person will provide, on request to the Securities and Exchange Commission Staff, the issuer, or a security holder of the issuer, full details on the number of shares sold at each separate price.
Concurrent option exercises
That same day, Klenk also exercised options to acquire a total of 16,712 shares of Travelers common stock in two separate exercises. One exercise covered 4,912 shares at an exercise price of $140.85 per share; the other covered 11,800 shares at an exercise price of $132.58 per share. The combined cash value associated with these option exercises is reported as $2,256,299.
Context from the company's quarter
Travelers reported operating earnings per share of $11.13 for the quarter, a result that exceeded both the analyst estimate of $8.92 and the consensus estimate of $8.76. Analysts cited several factors behind the stronger-than-expected performance, including favorable reserve development, lower catastrophe losses, a reduced accident year ex-catastrophe loss ratio, and higher net investment income.
Analyst reactions
Following the quarterly report and updated guidance for business insurance and net investment income, analysts adjusted their price targets and ratings:
- Raymond James raised its price target to $330, citing higher EPS estimates for 2026 and 2027.
- Jefferies reduced its price target to $305 but maintained a Hold rating despite the company’s strong results.
- UBS kept a Neutral rating with a $290 price target, noting the robust earnings and better-than-expected share buybacks.
- Mizuho moved its price target to $304, attributing the change to industry multiple compression while slightly increasing its EPS estimates for 2026 and 2027.
- Citizens reiterated a Market Perform rating in recognition of the strong quarterly performance.
Takeaway
The public filings show an insider sale of 16,712 shares at an average price of $279.7746 and simultaneous option exercises to acquire the same number of shares at substantially lower exercise prices, for a combined option exercise value of $2,256,299. These moves occurred alongside a quarter in which Travelers delivered operating EPS well above analyst and consensus expectations, prompting a range of analyst responses on price targets and ratings.